# Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis

> **NCT03810521** · PHASE1 · UNKNOWN · sponsor: **Universidad de los Andes, Chile** · enrollment: 24 (estimated)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **BIOLOGICAL:** umbilical cord derived-mesenchymal stromal cells

## Key facts

- **NCT ID:** NCT03810521
- **Lead sponsor:** Universidad de los Andes, Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2019-10-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2019-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03810521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03810521, "Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03810521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*